OIG Clears a Path for Limited ‘Quick Start’ Program in New Advisory Opinion

Recently, an increasing number of pharmaceutical manufacturers have sought to provide limited free supplies of their drugs to patients initiating therapy, including those who experience delays in obtaining insurance coverage.

Read more: OIG Clears a Path for Limited ‘Quick Start’ Program in New Advisory Opinion


Download PDF Share Back To Listing
Loading data